Intranasal Photobiomodulation as a Potential Treatment for Parkinson's Disease: A Randomized Placebo-Controlled Pilot Study
Sham showed a decline in MoCA. These findings suggest that intranasal PBM may be a promising adjunctive therapy for PD; further studies are needed to elucidate mechanisms and optimize treatment protocols.